<code id='0E992D3740'></code><style id='0E992D3740'></style>
    • <acronym id='0E992D3740'></acronym>
      <center id='0E992D3740'><center id='0E992D3740'><tfoot id='0E992D3740'></tfoot></center><abbr id='0E992D3740'><dir id='0E992D3740'><tfoot id='0E992D3740'></tfoot><noframes id='0E992D3740'>

    • <optgroup id='0E992D3740'><strike id='0E992D3740'><sup id='0E992D3740'></sup></strike><code id='0E992D3740'></code></optgroup>
        1. <b id='0E992D3740'><label id='0E992D3740'><select id='0E992D3740'><dt id='0E992D3740'><span id='0E992D3740'></span></dt></select></label></b><u id='0E992D3740'></u>
          <i id='0E992D3740'><strike id='0E992D3740'><tt id='0E992D3740'><pre id='0E992D3740'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:53496
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Decaf coffee targeted by food safety group under obscure FDA rule
          Decaf coffee targeted by food safety group under obscure FDA rule

          ApichartWeerawong/APWASHINGTON—There’safightbrewingoverthefutureofdecafcoffee.Consumerhealthadvocate

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

          PeterMarks,theFDA'stopregulatorofgenetherapies(right),speakswithSTAT'sAdamFeuersteininSanFrancisco.S